本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

44.72
+0.69001.57%
盘后44.720.00000.00%17:38 EDT
成交量:234.12万
成交额:1.05亿
市值:35.77亿
市盈率:-11.83
高:45.37
开:44.70
低:44.04
收:44.03
52周最高:58.40
52周最低:21.34
股本:7,998.90万
流通股本:6,777.24万
量比:2.89
换手率:3.45%
股息:- -
股息率:- -
每股收益(TTM):-3.7801
每股收益(LYR):-3.7544
净资产收益率:-31.14%
总资产收益率:-20.36%
市净率:3.49
市盈率(LYR):-11.91

数据加载中...

2021/03/12

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/16

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/15

重要事件披露

8-K - Current report
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/07/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/07

重要事件披露

8-K/A [Amend] - Current report
2020/07/06

SEC问询函

CORRESP [Cover] - Correspondence